2087 related articles for article (PubMed ID: 22995601)
1. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
Patzer A; Zhao Y; Stöck I; Gohlke P; Herdegen T; Culman J
Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
[TBL] [Abstract][Full Text] [Related]
3. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
4. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain.
Schmerbach K; Schefe JH; Krikov M; Müller S; Villringer A; Kintscher U; Unger T; Thoene-Reineke C
Brain Res; 2008 May; 1208():225-33. PubMed ID: 18378216
[TBL] [Abstract][Full Text] [Related]
5. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
[TBL] [Abstract][Full Text] [Related]
6. Continuous oral administration of atorvastatin ameliorates brain damage after transient focal ischemia in rats.
Saito T; Nito C; Ueda M; Inaba T; Kamiya F; Muraga K; Katsura K; Katayama Y
Life Sci; 2014 Jan; 94(2):106-14. PubMed ID: 24333133
[TBL] [Abstract][Full Text] [Related]
7. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
Zhao Y; Patzer A; Gohlke P; Herdegen T; Culman J
Eur J Neurosci; 2005 Jul; 22(1):278-82. PubMed ID: 16029218
[TBL] [Abstract][Full Text] [Related]
8. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats.
Zhao Y; Patzer A; Herdegen T; Gohlke P; Culman J
FASEB J; 2006 Jun; 20(8):1162-75. PubMed ID: 16770015
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
10. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
11. Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome.
Ji S; Kronenberg G; Balkaya M; Färber K; Gertz K; Kettenmann H; Endres M
Exp Neurol; 2009 Apr; 216(2):321-8. PubMed ID: 19146854
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
Gupta S; Sharma U; Jagannathan NR; Gupta YK
Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
[TBL] [Abstract][Full Text] [Related]
13. Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion.
Gamboa J; Blankenship DA; Niemi JP; Landreth GE; Karl M; Hilow E; Sundararajan S
Neuroscience; 2010 Oct; 170(3):846-57. PubMed ID: 20691766
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
15. Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.
Zuhayra M; Zhao Y; von Forstner C; Henze E; Gohlke P; Culman J; Lützen U
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):738-52. PubMed ID: 21366664
[TBL] [Abstract][Full Text] [Related]
16. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.
Hyakkoku K; Nakajima Y; Izuta H; Shimazawa M; Yamamoto T; Shibata N; Hara H
Neuroscience; 2009 Mar; 159(2):760-9. PubMed ID: 19166916
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
[TBL] [Abstract][Full Text] [Related]
19. Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia.
Andrabi SA; Spina MG; Lorenz P; Ebmeyer U; Wolf G; Horn TF
Brain Res; 2004 Aug; 1017(1-2):98-107. PubMed ID: 15261105
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of therapeutic time window of L-serine against focal cerebral ischemia/reperfusion injury in rats].
Wang GH; Jiang ZL; Zhang XG; Shen LH; Fan XJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Feb; 26(1):72-6. PubMed ID: 20476571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
